Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.

Date publication

janvier 2017

Journal

Digestion

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Allocca M, Landi R, Bonovas S, Fiorino G, Papa A, Spinelli A, Furfaro F, Peyrin-Biroulet L, Armuzzi A, Danese S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28903094

Résumé

Most Crohn's disease (CD) patients develop endoscopic recurrence within one year of intestinal resection. The best treatment method to prevent post-operative CD recurrence remains uncertain.

Mots clés

Abdominal surgery, Anti-tumour necrosis factor, Crohn’s disease, Recurrence

Référence

Digestion. 2017 ;96(3):166-172